WAL 801 CL Dry Syrup in Paediatric Atopic Dermatitis Patients
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Study to investigate the safety and efficacy of WAL 801 CL Dry Syrup on pruritus associated
with paediatric atopic dermatitis in comparison with that of Ketotifen Fumarate Dry Syrup and
to confirm the appropriateness of dosage of WAL801 Dry Syrup.